Research Report on Blood Product Industry in China, 2018-2022

SKU ID :CRI-10661365 | Published Date: 06-Nov-2017 | No. of pages: 70
Table of Contents Chapter I Basic Concept of Blood Products 1.1 Definition of Blood Products 1.2 Classification of Blood Products 1.2.1 Albumin 1.2.2 Immune Globulin 1.2.3 Coagulation Factors 1.2.4 Other Categories 1.3 Research Methods of Report 1.3.1 Parameters and Assumptions 1.3.2 Data Sources 1.3.3 About CRI Chapter II Overview of Global Blood Product Industry, 2013-2017 2.1 Industry Overview 2.1.1 Development Process 2.1.2 Market Competition 2.1.3 Supply Status 2.1.4 Demand Status 2.2 Major Blood Product Manufacturers in the Globe 2.2.1 CSL Behring 2.2.2 Baxter 2.2.3 Grifols S.A. 2.2.4 Octapharma Chapter III Operation Status of China Blood Product Industry, 2013-2017 3.1 Development Environment of China Blood Product Industry 3.1.1 Economy Environment 3.1.2 Policy Environment  Administrative Departments  Policies on Enterprise Establishment  Policies on Raw Material Purchasing  Policies on Blood Product Production  Policies on Blood Product Circulation 3.1.3 Medical Environment 3.2 Barriers to Entry in China Blood Product Market 3.2.1 Policy Barriers 3.2.2 Blood Source Barriers 3.2.3 Technology and Quality Control Capability 3.3 Analysis on Supply of Blood Products in China, 2013-2017 3.3.1 Overview of Production Status 3.3.2 Analysis of Major Products 3.3.3 Production Capacity and Output Volume of Albumin 3.3.4 Production Capacity and Output Volume of Immunoglobulin 3.3.5 Production Capacity and Output Volume of Coagulation Factors 3.4 Analysis on Demand for Blood Products in China, 2013-2017 3.4.1 Albumin 3.4.2 Immune Globulin 3.4.3 Coagulation Factors 3.5 Competition Pattern of China Blood Product Industry 3.5.1 Bargaining Power of Upstream Suppliers 3.5.2 Bargaining Power of Downstream Clients 3.5.3 Competition in Blood Product Industry 3.5.4 Potential Entrants of Blood Product Industry 3.5.5 Substitutes of Blood Products 3.6 Analysis on Import and Export of Blood Products in China 3.6.1 Import 3.6.2 Export Chapter IV Analysis of Major Blood Product Manufacturers in China, 2016-2018 4.1 Shanghai RAAS Blood Products Co., Ltd. 4.1.1 Enterprise Profile 4.1.2 Operation Status of Blood Products (4.2-4.16 are similar to 4.1) 4.2 Hualan Biological Engineering Co., Ltd. 4.3 Beijing Tiantan Biological Products Co., Ltd. 4.4 Zhenxing Biopharmaceutical & Chemical Inc. 4.5 Jiangxi Boya Bio-pharmaceutical Co., Ltd. 4.6 Guangdong Weilun Bio-pharmaceutical Co., Ltd. 4.7 Walvax Biotechnology Co., Ltd. 4.8 Wuhan Rui De Biological Products Co., Ltd. 4.9 Shenzhen Weiguang Biological Products Co., Ltd. 4.10 Guangdong Shuanglin Bio-pharmaceutical Co., Ltd. 4.11 Hunan Nanyue Pharmaceutical Co., Ltd. 4.12 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. 4.13 Green Cross (China) Biological Products Co., Ltd. 4.14 Guiyang Qianfeng Biological Products Co., Ltd. 4.15 Shandong Taibang Products Co., Ltd. 4.16 Subordinate Institutions of Biological Products of China National Biotec Group 4.17 Hebei Daan Pharmaceutical Co., Ltd. 4.18 Guangdong Danxia Bio-pharmaceutical Co., Ltd. 4.19 Harbin Pacific Bio-pharmaceutical Co., Ltd. 4.20 Shanxi Kangbao Biological Product Co., Ltd. Chapter V Analysis on Blood Product Industry Chain in China, 2016-2018 5.1 Supply of Blood Plasma 5.1.1 Development Status of Plasma Collection Stations in China 5.1.2 Cost of Plasma Collection 5.2 Production of Blood Products 5.2.1 Analysis of Gross Profit Rate 5.2.2 Analysis of Cost Trend 5.3 Price Trend of Blood Products Chapter VI Forecast on Development of China Blood Product Industry, 2018-2022 6.1 Factors Influencing the Development of China Blood Product Industry 6.1.1 Market Opportunities and Driving Forces 6.1.2 Risks and Challenges 6.2 Forecast on Supply of Blood Products in China, 2018-2022 6.2.1 Forecast on Production Capacity Expansion 6.2.2 Forecast on Lot Release 6.3 Forecast on Demand for Blood Products in China, 2018-2022 6.3.1 Forecast on Demand Trend 6.3.2 Forecast on Market Scale 6.3.3 Forecast on Demand of Niche Markets Selected Charts Chart Common Varieties and Functions of Albumin Chart Common Varieties and Functions of Immune Globulin Chart Common Varieties and Functions of Coagulation Factors Chart Global Blood Product Plasma Volume and Forecast, 2012-2022 Chart Global Blood Product Market Scale and Forecast, 2012-2022 Chart Sales Scale of Baxter International Blood Products, 2013-2017 Chart Sales Scale of CSL Behring Blood Products, 2013-2017 Chart Sales Scale of Grifols Blood Products, 2013-2017 Chart Blood Product Plasma Volume in China, 2013-2017 Chart Lot Release Volume of Blood Products in China, 2013-2017 Chart Major Blood Product Manufacturers in China, 2018 Chart Lot Release Volume of Albumin Products in China, 2013-2017 Chart Lot Release Volume of Immune Globulin Products in China, 2013-2017 Chart Lot Release Volume of Coagulation Factor Products in China, 2013-2017 Chart Market Size of China Blood Products, 2013-2017 Chart Market Size of Albumin Blood Products in China, 2013-2017 Chart Market Size of Immune Globulin Blood Products in China, 2013-2017 Chart Products of Shanghai RAAS Blood Products Co. Ltd., 2018 Chart Lot Release Volume of Human Serum Albumin of Shanghai RAAS, 2012-2017 Chart Revenue of Shanghai RAAS Blood Products, 2013-2017 Chart Lot Release Volume of Human Serum Albumin of Hualan Biological, 2013-2017 Chart Lot Release Volume of Human Serum Albumin of CSL Behring, 2013-2017 Chart Lot Release Volume of Human Serum Albumin of Grifols, 2013-2017 Chart Lot Release Volume of Human Serum Albumin of Baxter, 2013-2017 Chart Lot Release Volume of Human Serum Albumin of Octapharma, 2013-2017 Chart Quantity of Plasma Collection Stations in China, 2013-2017 Chart Forecast on the Market Size of Blood Products in China, 2018-2022 Chart Forecast on the Market Size of Albumin Products in China, 2018-2022 Chart Forecast on the Market Size of Immune Globulin Products in China, 2018-2022 Chart Forecast on the Market Size of Coagulation Factor Products in China, 2018-2022
1 Shanghai RAAS Blood Products Co., Ltd. 2 Hualan Biological Engineering Co., Ltd. 3 Beijing Tiantan Biological Products Co., Ltd. 4 Zhenxing Biopharmaceutical & Chemical Inc. 5 Jiangxi Boya Bio-pharmaceutical Co., Ltd. 6 Guangdong Weilun Bio-pharmaceutical Co., Ltd. 7 Walvax Biotechnology Co., Ltd. 8 Wuhan Rui De Biological Products Co., Ltd. 9 Shenzhen Weiguang Biological Products Co., Ltd. 10 Guangdong Shuanglin Bio-pharmaceutical Co., Ltd. 11 Hunan Nanyue Pharmaceutical Co., Ltd. 12 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. 13 Green Cross (China) Biological Products Co., Ltd. 14 Guiyang Qianfeng Biological Products Co., Ltd. 15 Shandong Taibang Products Co., Ltd. 16 Subordinate Institutions of Biological Products of China National Biotec Group 17 Hebei Daan Pharmaceutical Co., Ltd. 18 Guangdong Danxia Bio-pharmaceutical Co., Ltd. 19 Harbin Pacific Bio-pharmaceutical Co., Ltd. 20 Shanxi Kangbao Biological Product Co., Ltd.
  • PRICE
  • $2800
    $4200

Our Clients